Stephan Jackman
CIK: 0001864257
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALZN
Alzamend Neuro, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Jackman Stephan
Jackman Stephan (SEC CIK 0001864257) files insider reports with the SEC as Chief Executive Officer of Alzamend Neuro, Inc. (ALZN).
Signal8 holds 1 ownership filing by Jackman Stephan, a Form 5, filed on Aug 4, 2026. Those filings report 1 transaction, the latest on Apr 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jackman Stephan's filings is in ATLANTA, GA.
Recent filings by Jackman Stephan
- Apr 17, 2026: Grant or award of ALZN derivative securities (Form 5, code A).
Other insiders filing for Alzamend Neuro, Inc. (ALZN)
- Hyperscale Data, Inc., Director
- AULT MILTON C III, Director
- Nisser Henry Carl, EVP and General Counsel
- Horne William B., Director
- Oram Jeffrey, Director
- GUSTAFSON MARK, Director